BioStock article about Alzinova advancing ALZ-201

Date: 2022-06-01

Alzinova has taken the next important step to take ALZ-201 towards clinical studies by initiating the development of a stable cell line to produce high and stable levels of ALZ-201.  As such, Alzinova is working to have two candidates in clinical development targeting Alzheimer’s disease.